Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00635 Surgical Treatments of LymphedemaPayerPolicy · BCBSLA-00635-BD14E3038D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00634 Therapeutic Radiopharmaceuticals in OncologyPayerPolicy · BCBSLA-00634-B84485D9EF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00633 burosumab-twza (Crysvita)PayerPolicy · BCBSLA-00633-3C46E477B8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00632 Urea Cycle Disorder Pharmacologic Agents (Buphenyl, Ravicti, Pheburane, Olpruva, generics)PayerPolicy · BCBSLA-00632-6CFDDF04D1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00631 Sensipar, generics (cinacalcet)PayerPolicy · BCBSLA-00631-E346A39D18 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00630 Ethacrynic Acid Oral Products (Edecrin, generics)PayerPolicy · BCBSLA-00630-E54A5BF1C4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00629 parathyroid hormone (Natpara)- Retired PolicyPayerPolicy · BCBSLA-00629-3D696B7D5F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00628 dextromethorphan/quinidine (Nuedexta)PayerPolicy · BCBSLA-00628-CA771B26FD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00627 eltrombopag Products (Promacta, generics, Alvaiz)PayerPolicy · BCBSLA-00627-D3224CC61E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00626 Pheochromocytoma Medications (Demser, Dibenzyline, generics)PayerPolicy · BCBSLA-00626-8C361E0150 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00625 Select Drug Quantity ManagementPayerPolicy · BCBSLA-00625-E35E55B085 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00624 Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)PayerPolicy · BCBSLA-00624-0796263273 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00623 Solosec (secnidazole)PayerPolicy · BCBSLA-00623-E22363BBEC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00622 Gene Expression Profiling for Skin Cancer- Retired PolicyPayerPolicy · BCBSLA-00622-4413E58296 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00621 Outpatient Pulmonary RehabilitationPayerPolicy · BCBSLA-00621-C28EFB40CF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00620 tezacaftor/ivacaftor (Symdeko)PayerPolicy · BCBSLA-00620-71A0E13B98 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00619 desmopressin acetate (Nocdurna)PayerPolicy · BCBSLA-00619-6EF9D88C15 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00618 vestronidase alfa-vjbk (Mepsevii)PayerPolicy · BCBSLA-00618-C8F42842F9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00617 Lyrica CR, generics (pregabalin extended release)PayerPolicy · BCBSLA-00617-DA21EFA48B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00616 Trimpex (trimethoprim oral solution)--Retired PolicyPayerPolicy · BCBSLA-00616-8952DCC471 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00615 Naltrexone Implants/PelletsPayerPolicy · BCBSLA-00615-B7AAA6673B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00614 emicizumab (Hemlibra)PayerPolicy · BCBSLA-00614-CBACC36E73 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00613 Balloon Dilation of the Eustachian TubePayerPolicy · BCBSLA-00613-7A1E336C96 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00612 triamcinolone extended release intra-articular injection (Zilretta)PayerPolicy · BCBSLA-00612-B34FC2B736 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00611 Symproic (naldemedine) - Retired PolicyPayerPolicy · BCBSLA-00611-8BEDCBBC98 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00610 Extended Release Amantadine ProductsPayerPolicy · BCBSLA-00610-C8033CE789 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00609 CaroSpir (spironolactone oral suspension)PayerPolicy · BCBSLA-00609-6FFDC11A64 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00608 Gene Therapy for Inherited Retinal DystrophyPayerPolicy · BCBSLA-00608-1E1231292F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00607 infliximab-abda (Renflexis)- Retired PolicyPayerPolicy · BCBSLA-00607-8D981262D7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00606 benralizumab (Fasenra)PayerPolicy · BCBSLA-00606-CF193E9284 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00605 Chimeric Antigen Receptor T cell (CAR-T) TherapyPayerPolicy · BCBSLA-00605-2B57A87AAB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00604 L-Glutamine (Endari, generics)PayerPolicy · BCBSLA-00604-1292E72FAE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00603 Pharmacologic Treatment of Off Episodes in Parkinson DiseasePayerPolicy · BCBSLA-00603-55F59188D8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00602 methotrexate oral solution (Xatmep, Jylamvo)PayerPolicy · BCBSLA-00602-B679814CAD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00601 Select Drugs for Attention Deficit Hyperactivity Disorder (ADHD)PayerPolicy · BCBSLA-00601-5C30F65D89 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00599 Syndros (dronabinol)PayerPolicy · BCBSLA-00599-96D7DD2C52 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00598 Plugs for Anal Fistula RepairPayerPolicy · BCBSLA-00598-45FB45C88E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00597 Circulating Tumor DNA Management of Non-Small Cell Lung Cancer (Liquid Biopsy) - Retired PolicyPayerPolicy · BCBSLA-00597-E00A443B28 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00596 edaravone (Radicava, Radicava ORS, generics)PayerPolicy · BCBSLA-00596-11F4893DF4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00595 cerliponase alfa (Brineura)PayerPolicy · BCBSLA-00595-45DF345A6D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00594 Treatment of Hepatitis C with sofosbuvir/velpatasvir/voxilaprevir (Vosevi)PayerPolicy · BCBSLA-00594-57A12CE93E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00593 Treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)PayerPolicy · BCBSLA-00593-AB69DE5CA7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00592 Subtalar ArthroereisisPayerPolicy · BCBSLA-00592-D043779D10 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00591 Autonomic Nervous System TestingPayerPolicy · BCBSLA-00591-BEA1C2D8FD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00590 Interim Positron Emission Tomography Scanning in Oncology to Detect Early Response During Treatment-Retired PolicyPayerPolicy · BCBSLA-00590-F9709F9620 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00589 sarilumab (Kevzara)PayerPolicy · BCBSLA-00589-578E5EAD34 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00588 guselkumab (Tremfya)PayerPolicy · BCBSLA-00588-8A4E7044BD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00587 brodalumab (Siliq)PayerPolicy · BCBSLA-00587-1EBFCCF6B4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00586 nitisinone (Orfadin, Nityr, Harliku, generics)PayerPolicy · BCBSLA-00586-E95571D32C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00585 anakinra (Kineret)PayerPolicy · BCBSLA-00585-E7FCB47350 | New policy |
|---|